- Home
- CADL vs CEPV Comparison
CADL vs CEPV Comparison
Compare CADL & CEPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.67
Company Overview
Basic Information| Metric | CADL | CEPV |
|---|---|---|
| Founded | 1999 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.3M | 326.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CADL | CEPV |
|---|---|---|
| Price | $4.67 | $10.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 48.0K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $10.10 |
| 52 Week High | $9.08 | $10.35 |
Technical Indicators
Market Signals| Indicator | CADL | CEPV |
|---|---|---|
| Relative Strength Index (RSI) | 36.72 | 40.44 |
| Support Level | $4.57 | N/A |
| Resistance Level | $6.16 | $10.18 |
| Average True Range (ATR) | 0.23 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 5.06 | 20.00 |
Price Performance
Historical Comparison CADL
CEPV
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About CEPV Cantor Equity Partners V Inc. Class A Ordinary Shares
Cantor Equity Partners V Inc is a blank check company.